Calprotectin is raised in endogenous posterior uveitis

Ocular Immunology and Inflammation

Volumn 4, Issue 2, 1996, Pages 91-98

  Olson, John A ^a   Forrester, Marianne ^a   Clohessy, Paul A ^a   Golden, Barbara E ^a   Herriot, Richard ^a   Forrester, John V ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Antineutrophil; Calprotectin; Cytoplasmic antibody; Diagnosis; Uveitis

Indexed keywords

CALPROTECTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; LEUKOCYTE ACTIVATION; MALE; NEUTROPHIL; PLASMA; TOPICAL DRUG ADMINISTRATION; UVEITIS;

EID: 0029992427     PISSN: 09273948     EISSN: None     Source Type: Journal    
DOI: 10.3109/09273949609079638     Document Type: Article

References (30)

1. Forrester JV. Duke-Elder Lecture: new concepts on the role of autoimmunity in the pathogenesis of uveitis. Eye 1992; 6:433-446.
2. Dick AD, Cheng YF, Purdie AT, Liversidge J, Forrester JV. Immunocytochemical analysis of blood lymphocytes in uveitis. Eye 1992; 6:643-647.
3. Dick AD. Experimental approaches to specific immunotherapies in autoimmune disease: future treatment of endogenous posterior uveitis? Br J Ophthalmol 1995; 79:81-88.
4. Klok AM, Geertzen R, Rothova A, Baarsma GS, Kijlstra A. Anticardiolipin antibodies in uveitis. Curr Eye Res 1992; 11 Suppl:209-213.
5. Brandtzaeg P, Dale I, Gabrielsen TO. The leucocyte protein L1 (calprotectin): usefulness as an immunohistochemical marker antigen and putative biological function. Histopathology 1992; 21:191-196.
6. Fagerhol MK, Andersson KB, Naels-Andresen C-F, Brandtzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). Ch 10 in: Stimulus response coupling: The role of intracellular calcium binding proteins. Smith VL, Dedman JR (editors). Boca Raton: CRC Press, 1991.
7. Berntzen HB, Olmez U, Fagerhol MK, Munthe E. The leukocyte protein L1 in plasma and synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 1991; 20:74-82.
8. Sander J, Fagerhol MK, Bakken JS, Dale I. Plasma levels of the leukocyte Li protein in febrile conditions: relation to aetiology, number of leukocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984; 44:357-362.
9. Golden BE, Clohessy PA, Russell G, Fagerhol MK. Calprotectin as a marker of inflammation in cystic fibrosis. Arch Dis Child 1995; 74: 136-137.
10. Young DW. The antineutrophil antibody in uveitis. Br J Ophthalmol 1991; 75:208-211.
11. Young DW, Dring S, Thompson R. Anti-neutrophil cytoplasmic antibodies in uveitis. Curr Eye Res 1990; 9 Suppl:41-44.
12. Lock RJ. ACP Broadsheet No 143: January 1994. Detection of autoantibodies to neutrophil cytoplasmic antigens. J Clin Pathol 1994; 47:4-8.
13. Soukiasian SH, Foster CS, Niles JL, Raizman MB. Diagnostic value of antineutrophil cytoplasmic antibodies in scleritis associated with Wegener's granulomatosis. Ophthalmology 1992; 99:125-132.
14. Pulido JS, Goeken JA, Nerad JA, Sobol WM, Folberg R. Ocular manifestations of patients with circulating antineutrophil cytoplasmic antibodies. Arch Ophthalmol 1990; 108:845-850.
15. de Keizer RJ, van der Woude FJ. cANCA test and the detection of Wegener's disease in sclerokeratitis and uveitis. Curr Eye Res 1990; 9 Suppl:59-61.
16. Gross WL, Schmitt WH, Csernok E. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunnol 1993; 91:1-12.
17. Hagen EC, van de Vijver-Reenalda H, de Keizer RJ, et al. Uveitis and antineutrophil cytoplasmic antibodies. Clin Exp Immunol 1994; 95:56-59.
18. Roseth AG, Fagerhol MK, Schjonsby H. Assessment of the neutrophil dominating protein calprotectin in faeces. Scand J Gastroenterol 1992; 27:793-798.
19. Wilk A. Delineation of a standard procedure for direct immunofluorescence detection of ANCA. Acta Pathol Microbiol Immunol Scand 1989; 97 (S6):12-14.
20. Forrester JV. Uveitis pathogenesis. Lancet 1991; 338:1498-1501.
21. Forrester JV, Stott D, Hercus K. Naturally occurring antibodies to bovine and human retinal S-Ag. A comparison between uveitis patients and healthy controls. Br J Ophthalmol 1989; 73:155-159-
22. Gregerson DS, Abrahams IW, Thurkill CE. Serum antibody levels of uveitis patients to bovine retinal antigens. Invest Ophthalmol Vis Sci 1981; 21:669-680.
23. deSmet MD, Yakamoto JH, Ger I, Singh VK, Shinohara T, et al. Cellular immune responses of patients with uveitis to retinal antigens and their fragments. Am J Ophthalmol 1990; 110:135-142.
24. Edelsten C, D'Cruz D, Hughes GR, Graham EM. Anti-endothelial cell antibodies in retinal vasculitis. Curr Eye Res 1992; 11 Suppl:203-208.
25. Zaman AG, Edelsten C, Mason JA, et al. Circulating VCAM-1 is raised in patients with isolated idiopathic retinal vasculitis. Regional Immunol 1994; 6:64-68.
26. Herbort CP, Okumura A, Mochizuki M. Endotoxin-induced uveitis in the rat. A study of the role of inflammation mediators. Graefe's Arch Clin Exp Ophthalmol 1988; 226:553-558.
27. Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scand J Immunol 1995; 42:551-556.
28. Radke LL, Hahn BL, Wagner DK, Sohnle PG. Comparison of the metal-binding anti-candidial activities of serum and abscess fluid supernatants. J Med Vet Mycol 1994; 32:295-301.
29. Murao S, Collart F, Huberman E. A protein complex expressed during terminal differentiation of non-myelocytic cells is an inhibitor of cell growth. Cell Growth Differentiation 1990; 1:447-454.
30. Kallenberg CGM, Cohen Tervaert JW, van der Woude FJ, Goldschmeding R, von dem Borne AEGKr, Weening JJ. Autoimmunity to lysosomal enzymes: new clues to vasculitis and glomerulonephritis? Immunol Today 1991; 12:61-64.